Streamlined, Robust and Cost-Effective NGS Enrichment
Current methods of targeted next-generation sequencing (NGS) enrichment are intricate, labor-intensive and can take days to accomplish. In addition, samples commonly fail analysis due to insufficient amounts of nucleic acid or insufficient coverage of target regions, missing important variant calls.
With increasing labor costs, an inefficient clinical laboratory procedure results in added pressure to your laboratory's bottom line.
Pillar Biosciences addresses these challenges with a simplified NGS SLIMamp technology, offering clinical NGS panels that are simple to implement, robust in sensitivity and specificity, and cost-effective to run.